Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Serum cholesterol esterifying and cholesteryl ester hydrolyzing activities in liver diseases: relationships to cholesterol, bilirubin, and bile salt concentrations
Don P. Jones, … , Eileen Skromak, William T. Beher
Don P. Jones, … , Eileen Skromak, William T. Beher
Published February 1, 1971
Citation Information: J Clin Invest. 1971;50(2):259-265. https://doi.org/10.1172/JCI106490.
View: Text | PDF
Research Article

Serum cholesterol esterifying and cholesteryl ester hydrolyzing activities in liver diseases: relationships to cholesterol, bilirubin, and bile salt concentrations

  • Text
  • PDF
Abstract

Patients with acute hepatitis and chronic alcoholic liver disease had decreased net serum cholesterol esterifying activity (CEA) which correlated positively with the percentages and concentrations of cholesteryl esters in their serum. These cholesterol parameters also correlated negatively with serum bilirubin concentrations, but bilirubin added to sera in vitro failed to influence CEA. The decreased net CEA in the patients was not due to its inhibition by serum bile salts. The sera from five patients catalyzed a net hydrolysis of cholesteryl esters rather than a net esterification of free cholesterol. Since serum cholesteryl ester hydrolase activity may also have been present in the patients with decreased CEA, net CEA cannot be equated with the activity of lecithin-cholesterol acyl transferase (LCAT) in patients with liver disease. The relative contributions of LCAT and cholesteryl ester hydrolase activities to CEA in disease states remain to be evaluated by mutually independent assays. Nevertheless, the correlations found between net CEA and the concentrations and percentages of cholesteryl esters support the concepts that serum cholesterol esterifying activity is physiologically important in the formation of serum cholesteryl esters and that decreased CEA is one mechanism for the decreased level of cholesteryl esters seen in patients with liver diseases.

Authors

Don P. Jones, Freddy R. Sosa, Jack Shartsis, Praful T. Shah, Eileen Skromak, William T. Beher

×

Total citations by year

Year: 2022 2021 2017 2016 2015 2007 1995 1992 1989 1984 1979 1978 1977 1976 1975 1974 1973 1972 1965 Total
Citations: 1 1 2 1 1 1 1 1 1 1 1 2 1 3 1 4 1 4 1 29
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (29)

Title and authors Publication Year
HCV Infection and Liver Cirrhosis Are Associated with a Less-Favorable Serum Cholesteryl Ester Profile Which Improves through the Successful Treatment of HCV.
Weigand K, Peschel G, Grimm J, Müller M, Höring M, Krautbauer S, Liebisch G, Buechler C
Biomedicines 2022
Current Status of Familial LCAT Deficiency in Japan
M Kuroda, H Bujo, K Yokote, T Murano, T Yamaguchi, M Ogura, K Ikewaki, M Koseki, Y Takeuchi, A Nakatsuka, M Hori, K Matsuki, T Miida, S Yokoyama, J Wada, M Harada-Shiba
Journal of Atherosclerosis and Thrombosis 2021
Cholesterol esterification in plasma as a biomarker for liver function and prediction of mortality
T Kaiser, B Kinny-Köster, M Bartels, T Berg, M Scholz, C Engelmann, D Seehofer, S Becker, U Ceglarek, J Thiery
BMC Gastroenterology 2017
BIOCHEMISTRY OF SERUM AND BILE CHOLELITHIASIS: Author's Reply.
Medical Journal Armed Forces India 2017
Circulating sterols as predictors of early allograft dysfunction and clinical outcome in patients undergoing liver transplantation
U Ceglarek, K Kresse, S Becker, GM Fiedler, J Thiery, M Quante, R Wieland, M Bartels, G Aust
Metabolomics 2016
Comparative Analyses of QTLs Influencing Obesity and Metabolic Phenotypes in Pigs and Humans
SD Pant, P Karlskov-Mortensen, MJ Jacobsen, S Cirera, LJ Kogelman, CS Bruun, T Mark, CB Jørgensen, N Grarup, EV Appel, EA Galjatovic, T Hansen, O Pedersen, M Guerin, T Huby, P Lesnik, TH Meuwissen, HN Kadarmideen, M Fredholm, RN SUBIRÀ
PloS one 2015
Lipoprotein profile in cirrhosis of liver
JS Varghese, K Krishnaprasad, R Upadhuyay, MS Revathy, V Jayanthi
European Journal of Gastroenterology & Hepatology 2007
STUDY OF SERUM AND BILE FROM PATIENTS OF CHOLELITHIASIS IN NORTH-EASTERN INDIA
PK Menon, S MAHAPATRA
Medical Journal Armed Forces India 1995
Medical and Nutritional Complications of Alcoholism
CS Lieber
1992
Carbohydrate metabolism in uremia
RH Mak
Pediatric Nephrology 1989
Action of a microbial glycerophospholipid:cholesterol acyltransferase on plasma from normal and LCAT-deficient subjects
JT Buckley, R McLeod, J Frohlich
Journal of lipid research 1984
Studies on cholesterol ester formation and hydrolysis in liver disease: a selective review
JB Simon
The Yale journal of biology and medicine 1979
A Rapid Method for Lecithin: Cholesterol Actyltransferase Estimation in Human Serum
LG Alcindor, A Dusser, MC Piot, R Infante, J Polonovski
Scandinavian Journal of Clinical & Laboratory Investigation 1978
Hepatic cholesterol ester hydrolase in human liver disease
JB Simon, RW Poon
Gastroenterology 1978
The effect of hepatitis B on plasma cholesterol and sterol balance
CD Saudek
The American Journal of Medicine 1977
The influence of LP-X and other lipoproteins associated with hepatic dysfunction on the activity of lecithin :Cholesterol acyltransferase
HN Magnani
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism 1976
Rapid enzymatic determination of free and esterified cholesterol content of serum and tissues
RJ Morin
Clinica Chimica Acta 1976
Plasma Cholesterol Esterification in Liver Disease
JP Blomhoff
Scandinavian Journal of Gastroenterology 1976
Clinical and Physiological Abnormalities in Hepatic Function
RJ Grand, MH Ulshen
Pediatric Clinics of North America 1975
Lecithin: Cholesterol Acyltransferase in Human Liver Disease
JB Simon
Scandinavian Journal of Clinical & Laboratory Investigation 1974
Apolipoproteins and Lipoprotein Families in Familial Lecithin: Cholesterol Acyltransferase Deficiency
P Alaupovic, WJ McConathy, MD Curry, HN Magnani, H Torsvik, K Berg, E Gjone
Scandinavian Journal of Clinical & Laboratory Investigation 1974
In Vitro Determination of Lecithin: Cholesterol Acyltransferase in Plasma
JP Blomhoff
Scandinavian Journal of Clinical & Laboratory Investigation 1974
Serum Cholesterol Esterification in Human Liver Disease: Role of Lecithin-Cholesterol Acyltransferase and Cholesterol Ester Hydrolase
JB Simon, DL Kepkay, R Poon
Gastroenterology 1974
Does lipoprotein-X (LP-X) act as a substrate for the lecithin: Cholesterol acyltransferase (LCAT)?
H Wengeler, D Seidel
Clinica Chimica Acta 1973
An Analysis of Lipoproteins, Bile Acids, and Red Cell Membranes Associated with Target Cells and Spur Cells in Patients with Liver Disease
RA Cooper, MD Puray, P Lando, MS Greenverg
Journal of Clinical Investigation 1972
Sequential Changes of the Plasma Protein Pattern in Inoculation Hepatitis
CO Kindmark, CB Laurell
Scandinavian Journal of Clinical & Laboratory Investigation 1972
The existence of an acid cholesterol esterase in human liver
KT Stokke
Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism 1972
Achtundsiebzigster Kongress
B Schlegel
1972
Advances in Lipid Research
AM Scanu
Advances in Lipid Research 1965

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts